The reformulated vaccine defends against new omicron strains, including XBB omicron variants. The panel stopped short of ...

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here's what we know.

A panel of experts on Thursday agreed that the bivalent COVID-19 vaccines should be used as both initial and booster shots, ...

Those who have received a bivalent COVID-19 booster may be wondering what next steps look like for vaccination and whether ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

It's part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine.

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

The Vaccines and Related Biological Products Advisory Committee meets Thursday to consider how to update guidelines for COVID-19 booster shots.

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...